Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bièche

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Genes, Chromosomes & Cancer|April 1, 1995
Loss of heterozygosity on 7q31 occurs early during breast tumorigenesisM H Champème, I Bièche, M Beuzelin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 1, 1994
Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancerM H Champème, I Bièche, K Hacène, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
(C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancerJ C Zenklusen, I Bièche, R Lidereau, et al.
Carcinogenesis|September 5, 2001
Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated geneI Bièche, B Parfait, S Tozlu, et al.
British Journal of Cancer|March 1, 2002
Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assaysI Bièche, M Olivi, C Noguès, et al.
Thyroid : Official Journal of the American Thyroid Association|April 6, 2001
Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reactionI Bièche, B Franc, D Vidaud, et al.
Archives of Pathology & Laboratory Medicine|May 24, 2001
Fluorescence in situ hybridization and immunohistochemical assays for HER-2/neu status determination: application to node-negative breast cancerP Onody, F Bertrand, F Muzeau, et al.
Cancer Research|May 30, 1998
Location of several putative genes possibly involved in human breast cancer progressionK Driouch, M Briffod, I Bièche, et al.
British Journal of Cancer|January 1, 1997
Classical gene amplifications in human breast cancer are not associated with distant solid metastasesK Driouch, M H Champème, M Beuzelin, et al.
Bulletin Du Cancer|January 1, 1992
[Association studies in cancerology: the example of gene L-myc polymorphism associated with the incidence of pulmonary metastases in breast cancers]M H Champème, I Bièche, A Latil, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Genes, Chromosomes & Cancer|April 1, 1995
Loss of heterozygosity on 7q31 occurs early during breast tumorigenesisM H Champème, I Bièche, M Beuzelin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 1, 1994
Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancerM H Champème, I Bièche, K Hacène, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
(C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancerJ C Zenklusen, I Bièche, R Lidereau, et al.
Carcinogenesis|September 5, 2001
Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated geneI Bièche, B Parfait, S Tozlu, et al.
British Journal of Cancer|March 1, 2002
Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assaysI Bièche, M Olivi, C Noguès, et al.
Thyroid : Official Journal of the American Thyroid Association|April 6, 2001
Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reactionI Bièche, B Franc, D Vidaud, et al.
Archives of Pathology & Laboratory Medicine|May 24, 2001
Fluorescence in situ hybridization and immunohistochemical assays for HER-2/neu status determination: application to node-negative breast cancerP Onody, F Bertrand, F Muzeau, et al.
Cancer Research|May 30, 1998
Location of several putative genes possibly involved in human breast cancer progressionK Driouch, M Briffod, I Bièche, et al.
British Journal of Cancer|January 1, 1997
Classical gene amplifications in human breast cancer are not associated with distant solid metastasesK Driouch, M H Champème, M Beuzelin, et al.
Bulletin Du Cancer|January 1, 1992
[Association studies in cancerology: the example of gene L-myc polymorphism associated with the incidence of pulmonary metastases in breast cancers]M H Champème, I Bièche, A Latil, et al.
Pageof 10